mitogen-activated protein kinase kinase 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of axonogenesis | ||
| face development | ||
| trachea formation | ||
| epithelial cell proliferation involved in lung morphogenesis | ||
| ERK1 and ERK2 cascade |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| nucleus | ||
| mitochondrion | ||
| early endosome | ||
| late endosome |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein serine/threonine kinase activity | ||
| MAP kinase kinase activity | ||
| MAP kinase kinase activity | ||
| protein serine/threonine/tyrosine kinase activity | ||
| protein tyrosine kinase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111463 | cardiofaciocutaneous syndrome 4 | |
| DOID:4906 | small intestine adenocarcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026